Internal Antibody Discovery Programs

About Biocytogen

Biocytogen is a preclinical-stage biotechnology company providing critical tools and services for drug discovery, primarily through its genetically engineered mouse model platforms. The company's core offerings include its RenMice platforms, which generate fully humanized antibodies, and a suite of custom and off-the-shelf animal models for target validation and efficacy studies. By serving as a research enabler for pharmaceutical and biotech companies, Biocytogen operates a platform-and-services business model aimed at de-risking early-stage therapeutic development. Its strategic position in Boston provides access to a dense network of life sciences talent and potential partners.

Therapeutic Areas

Other Oncology, Immunology Drugs